Skip to main content
Top
Published in: Surgical Endoscopy 4/2017

Open Access 01-04-2017 | New Technology

A new technique for minimally invasive irreversible electroporation of tumors in the head and body of the pancreas

Authors: David Stillström, Henrik Nilsson, Michaela Jesse, Matthias Peterhans, Eduard Jonas, Jacob Freedman

Published in: Surgical Endoscopy | Issue 4/2017

Login to get access

Abstract

Background

Palliative irreversible electroporation of pancreatic adenocarcinomas is rapidly gaining in interest since a large proportion of these patients cannot be radically resected.

Methods

This is a description of a minimally invasive approach to irreversible electroporation of pancreatic tumors using computer-assisted navigation, laparoscopy and laparoscopic ultrasound to correctly guide electrodes into the tissue.

Results

The procedure is presented.

Conclusion

Minimally invasive irreversible electroporation of pancreatic tumors through computer-assisted navigation of needles during laparoscopy is a feasible and accurate approach.
Appendix
Available only for authorised users
Literature
1.
go back to reference Yeo TP (2015) Demographics, epidemiology, and inheritance of pancreatic ductal adenocarcinoma. Semin Oncol 42(1):8–18CrossRefPubMed Yeo TP (2015) Demographics, epidemiology, and inheritance of pancreatic ductal adenocarcinoma. Semin Oncol 42(1):8–18CrossRefPubMed
2.
go back to reference Ferrone CR, Pieretti-Vanmarcke R, Bloom JP, Zheng H, Szymonifka J, Wargo JA et al (2012) Pancreatic ductal adenocarcinoma: long-term survival does not equal cure. Surgery 152(3 Suppl 1):S43–S49CrossRefPubMedPubMedCentral Ferrone CR, Pieretti-Vanmarcke R, Bloom JP, Zheng H, Szymonifka J, Wargo JA et al (2012) Pancreatic ductal adenocarcinoma: long-term survival does not equal cure. Surgery 152(3 Suppl 1):S43–S49CrossRefPubMedPubMedCentral
3.
go back to reference Sohn TA, Yeo CJ, Cameron JL, Koniaris L, Kaushal S, Abrams RA et al (2000) Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators. J Gastrointest Surg 4(6):567–579CrossRefPubMed Sohn TA, Yeo CJ, Cameron JL, Koniaris L, Kaushal S, Abrams RA et al (2000) Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators. J Gastrointest Surg 4(6):567–579CrossRefPubMed
4.
go back to reference Oh SY, Edwards A, Mandelson MT, Lin B, Dorer R, Helton WS et al (2015) Rare long-term survivors of pancreatic adenocarcinoma without curative resection. World J Gastroenterol 21(48):13574–13581CrossRefPubMedPubMedCentral Oh SY, Edwards A, Mandelson MT, Lin B, Dorer R, Helton WS et al (2015) Rare long-term survivors of pancreatic adenocarcinoma without curative resection. World J Gastroenterol 21(48):13574–13581CrossRefPubMedPubMedCentral
5.
6.
go back to reference Pugalenthi A, Protic M, Gonen M, Kingham TP, Angelica MI, Dematteo RP et al (2015) Postoperative complications and overall survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma. J Surg Oncol 113:188–193CrossRefPubMedPubMedCentral Pugalenthi A, Protic M, Gonen M, Kingham TP, Angelica MI, Dematteo RP et al (2015) Postoperative complications and overall survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma. J Surg Oncol 113:188–193CrossRefPubMedPubMedCentral
8.
go back to reference Pandya GJ, Shelat VG (2015) Radiofrequency ablation of pancreatic ductal adenocarcinoma: the past, the present and the future. World J Gastrointest Oncol 7(2):6–11PubMedPubMedCentral Pandya GJ, Shelat VG (2015) Radiofrequency ablation of pancreatic ductal adenocarcinoma: the past, the present and the future. World J Gastrointest Oncol 7(2):6–11PubMedPubMedCentral
9.
go back to reference Rombouts SJ, Vogel JA, van Santvoort HC, van Lienden KP, van Hillegersberg R, Busch OR et al (2015) Systematic review of innovative ablative therapies for the treatment of locally advanced pancreatic cancer. Br J Surg 102(3):182–193CrossRefPubMed Rombouts SJ, Vogel JA, van Santvoort HC, van Lienden KP, van Hillegersberg R, Busch OR et al (2015) Systematic review of innovative ablative therapies for the treatment of locally advanced pancreatic cancer. Br J Surg 102(3):182–193CrossRefPubMed
10.
go back to reference Martin RC 2nd, Kwon D, Chalikonda S, Sellers M, Kotz E, Scoggins C et al (2015) Treatment of 200 locally advanced (stage III) pancreatic adenocarcinoma patients with irreversible electroporation: safety and efficacy. Ann Surg 262(3):486–494 (discussion 92–94) CrossRefPubMed Martin RC 2nd, Kwon D, Chalikonda S, Sellers M, Kotz E, Scoggins C et al (2015) Treatment of 200 locally advanced (stage III) pancreatic adenocarcinoma patients with irreversible electroporation: safety and efficacy. Ann Surg 262(3):486–494 (discussion 92–94) CrossRefPubMed
11.
go back to reference Peterhans M, vom Berg A, Dagon B, Inderbitzin D, Baur C, Candinas D et al (2011) A navigation system for open liver surgery: design, workflow and first clinical applications. Int J Med Robot 7(1):7–16CrossRefPubMed Peterhans M, vom Berg A, Dagon B, Inderbitzin D, Baur C, Candinas D et al (2011) A navigation system for open liver surgery: design, workflow and first clinical applications. Int J Med Robot 7(1):7–16CrossRefPubMed
Metadata
Title
A new technique for minimally invasive irreversible electroporation of tumors in the head and body of the pancreas
Authors
David Stillström
Henrik Nilsson
Michaela Jesse
Matthias Peterhans
Eduard Jonas
Jacob Freedman
Publication date
01-04-2017
Publisher
Springer US
Published in
Surgical Endoscopy / Issue 4/2017
Print ISSN: 0930-2794
Electronic ISSN: 1432-2218
DOI
https://doi.org/10.1007/s00464-016-5173-6

Other articles of this Issue 4/2017

Surgical Endoscopy 4/2017 Go to the issue